Immutable evidence record · ticker
Alnylam Pharmaceuticals, Inc. (A1LN34)
Published as observed on 20 August 2026 at 02:01 BST.
Alnylam Pharmaceuticals, Inc. has a negative company news read. Its latest completed weekly trend is negative.
- As of
- 20 Aug 2026, 02:01
- Scope
- company and instrument
- Evidence
- 21 items
- Independent sources
- 3
- Country
- Brazil
- Sector
- Healthcare
- Previous read
- 43.000
- Change
- 1.000
Verification
Evidence & related research
Company chart →Technicals & Market Dynamics →Technical Research Pack →Company news sentiment →Current financial news →
This is dated market research. Coverage may be delayed, incomplete or unavailable.
Cite this record:
Sharemaestro, Alnylam Pharmaceuticals, Inc. (A1LN34), 2026-08-20, https://sharemaestro.com/evidence/90f0cd97-a899-4670-a06b-b4a71e5867b8/
Record checksum 7d4e911d6e4e39ae68603d49947efb6f0191c568f000ec56920d51a9da580018
